SEPRILOSE

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C16H30O6
Molecular Weight	318.4058
Optical Activity	UNSPECIFIED
Defined Stereocenters	5 / 5
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CCCCCCCO[C@H]1[C@H](O[C@@H]2OC(C)(C)O[C@H]12)[C@H](O)CO

InChI

InChIKey=GWSUUEYOBZZHIJ-UXXRCYHCSA-N

InChI=1S/C16H30O6/c1-4-5-6-7-8-9-19-13-12(11(18)10-17)20-15-14(13)21-16(2,3)22-15/h11-15,17-18H,4-10H2,1-3H3/t11-,12-,13+,14-,15-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C16H30O6
Molecular Weight	318.4058
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	5 / 5
E/Z Centers	0
Optical Activity	UNSPECIFIED

Description
Sources: https://adisinsight.springer.com/drugs/800003766

Seprilose is a carbohydrate compound that inhibits prostaglandin E2 synthesis. Seprilose was undergoing phase II trials with Boston Life Sciences in the USA for the treatment of Rheumatic disorders, but this development was discontinued.

Originator

Approval Year

Patents

Substance Class	Chemical Created by `admin` on `Mon Mar 31 18:05:45 GMT 2025` Edited by `admin` on `Mon Mar 31 18:05:45 GMT 2025`
Record UNII	5764EUK72N
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

GW-80126

Preferred Name

English

SEPRILOSE

Official Name

English

seprilose [INN]

Common Name

English

Seprilose [WHO-DD]

Common Name

English

SEPRILOSE [USAN]

Common Name

English

GW80126

Code

English

Classification Tree Code System Code

NCI_THESAURUS

C344